ACME UNITED CORP - 10-Q Summary (Q2 2025)
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Acme United Corporation manufactures and distributes first aid, medical, cutting, and sharpening products. The company operates in three reportable segments: United States, Canada, and Europe. The registrant is an accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Net Sales | $53,996,000 | $55,425,000 | $99,954,000 | $100,382,000 |
| Gross Profit | $22,149,000 (41.0%) | $22,627,000 (40.8%) | $40,066,000 (40.1%) | $40,024,000 (39.9%) |
| Operating Income | $6,390,000 | $6,375,000 | $8,816,000 | $8,934,000 |
| Net Income | $4,752,000 | $4,452,000 | $6,404,000 | $6,089,000 |
| Diluted EPS | $1.16 | $1.09 | $1.57 | $1.47 |
| Cash & Equivalents | $3,641,000 (as of June 30, 2025) | |||
| Working Capital | $77,867,000 (as of June 30, 2025) | |||
| Long-Term Debt | $16,352,000 (as of June 30, 2025) |
Material Changes vs. Prior Period
- Revenue: Consolidated net sales decreased 3% in Q2 and 0.4% YTD compared to 2024. The U.S. segment saw a 5% decline in Q2, attributed to cancelled back-to-school orders due to high tariffs and the absence of a large one-time order from a mass market retailer that occurred in Q2 2024.
- Segment Performance:
- Canada: Sales increased 28% in Q2 and 18% YTD, driven by strong first aid product sales.
- Europe: Sales decreased 3% in Q2 and 5% YTD due to shipment delays and the lack of a large promotion seen in Q1 2024.
- Profitability: Despite lower sales, operating income remained relatively flat in Q2 (+0.2%) and YTD (-1.3%) due to effective cost reductions in SG&A expenses.
- Interest Expense: Net interest expense decreased 26% in Q2 and 19% YTD due to lower average outstanding borrowings and interest rates.
- Cash Flow: Net cash provided by operating activities improved significantly to $2,998,000 YTD 2025, compared to a use of $3,270,000 in YTD 2024.
Guidance, Outlook, Risks, and Unusual Items
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of June 30, 2025, due to a material weakness in IT general controls regarding logical security and privileged access. Remediation is expected to be completed by December 31, 2025.
- Tariff Risks: The company faces significant risks from U.S. tariffs on goods sourced from China, which have increased costs and led to order cancellations. Management is diversifying supply chains but notes uncertainty regarding future trade policies.
- Debt Facility: On June 26, 2025, the company extended its $65 million revolving credit facility maturity to May 31, 2027. As of June 30, 2025, $16.4 million was outstanding with $48.6 million available.
- Acquisition: The company acquired Elite First Aid in May 2024. A contingent payment of $500,000 is recorded as a liability, contingent on revenue milestones through December 31, 2025.
- Outlook: Management believes cash from operations and the credit facility are sufficient to finance operations for the next 12 months. No specific forward-looking financial guidance was provided in this text.
Investor Verification Checklist
- Material Weakness Remediation: Verify the timeline and effectiveness of the remediation plan for the IT general controls weakness identified in Q2.
- Tariff Impact: Monitor the extent of order cancellations and cost pass-through capabilities regarding Chinese tariffs in the U.S. segment.
- Canada Growth Sustainability: Assess whether the 28% sales growth in Canada is sustainable or driven by temporary factors.
- Inventory Levels: Review inventory turnover (2.1x) and the $57.3 million inventory balance to ensure no obsolescence risks given the sales slowdown in the U.S.
- Debt Covenants: Confirm continued compliance with the funded debt to EBITDA and fixed charge coverage ratios under the amended HSBC loan agreement.